Suppr超能文献

复发性掌腱膜挛缩的手术治疗。

Surgical Treatment for Recurrent Dupuytren Disease.

机构信息

INTEGRIS Health, Oklahoma City, OK, USA.

出版信息

Hand (N Y). 2023 Jun;18(4):641-647. doi: 10.1177/15589447211060447. Epub 2021 Dec 28.

Abstract

BACKGROUND

Revision procedures for recurrent Dupuytren disease (DD) can be difficult and carry a high risk of complications. Our goal was to describe surgical strategies used for cases of recurrence and report on their outcomes.

METHODS

We reviewed 1 surgeon's operative cases for recurrent DD performed at 1 institution. Prior procedures included collagenase injection, percutaneous needle fasciotomy, or open surgical fasciectomy in the same digit or area of the hand.

RESULTS

From January 1981 to December 2020, 54 procedures were performed on 33 patients for recurrent DD. Most patients were men (82%), had bilateral involvement (64%) and family history (52%), and some had ectopic disease in their feet (24%). The small finger was involved in 76% of the cases, and the proximal interphalangeal (PIP) joint was involved in 83% of these digits. The procedures included 38 partial fasciectomies (72%), 12 dermofasciectomies (23%), 3 radical fasciectomies (6%), 1 of each needle fasciotomy, ray amputation, and PIP joint arthrodesis (2%). Twenty-three patients (43%) required full thickness skin grafts with an average area of 7.1 cm (range: 1-20 cm).

CONCLUSIONS

This study highlights the complexity of recurrent DD case management and found the treatment required for 95% of patients in this series was open partial fasciectomy with or without demofasciectomy. Full thickness skin grafting was necessary in nearly half of the cases.

摘要

背景

复发性掌腱膜挛缩症(DD)的翻修手术较为困难,且并发症风险较高。我们的目的是描述用于复发性 DD 病例的手术策略,并报告其结果。

方法

我们回顾了 1 位外科医生在 1 家机构进行的复发性 DD 手术病例。先前的手术包括胶原酶注射、经皮针刀切开术或同一手指或手部区域的开放性筋膜切开术。

结果

1981 年 1 月至 2020 年 12 月,33 例患者共进行了 54 次复发性 DD 手术。大多数患者为男性(82%),双侧受累(64%),有家族史(52%),一些患者足部有异位病变(24%)。小指受累占 76%,近端指间关节(PIP)受累占这些手指的 83%。手术包括 38 例部分筋膜切开术(72%)、12 例皮筋膜切开术(23%)、3 例根治性筋膜切开术(6%)、各 1 例针刀切开术、射线切除术和 PIP 关节融合术(2%)。23 例患者(43%)需要全厚皮片移植,平均面积为 7.1cm(范围:1-20cm)。

结论

本研究强调了复发性 DD 病例管理的复杂性,并发现本研究系列中 95%的患者需要开放性部分筋膜切开术,必要时联合皮筋膜切开术。近一半的病例需要全厚皮片移植。

相似文献

1
Surgical Treatment for Recurrent Dupuytren Disease.
Hand (N Y). 2023 Jun;18(4):641-647. doi: 10.1177/15589447211060447. Epub 2021 Dec 28.
3
Outcomes and Direct Costs of Needle Aponeurotomy, Collagenase Injection, and Fasciectomy in the Treatment of Dupuytren Contracture.
J Hand Surg Am. 2019 Nov;44(11):919-927. doi: 10.1016/j.jhsa.2019.07.017. Epub 2019 Sep 17.
6
Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for dupuytren contracture.
J Hand Surg Am. 2011 Nov;36(11):1826-1834.e32. doi: 10.1016/j.jhsa.2011.08.004. Epub 2011 Oct 5.
7
Outcomes of Management of Recurrent Dupuytren Contracture: A Systematic Review and Meta-analysis.
Hand (N Y). 2022 Nov;17(6):1104-1113. doi: 10.1177/1558944721994220. Epub 2021 Feb 22.
8
Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.
JAMA Netw Open. 2020 Oct 1;3(10):e2019861. doi: 10.1001/jamanetworkopen.2020.19861.
9
Dupuytren Disease Management Trends: A Survey of Hand Surgeons.
Hand (N Y). 2020 Jan;15(1):97-102. doi: 10.1177/1558944718787281. Epub 2018 Jul 25.
10
A 10-Year Review of Collagenase Versus Fasciectomy in the Treatment of Dupuytren Contracture.
Ann Plast Surg. 2024 Jun 1;92(6):642-646. doi: 10.1097/SAP.0000000000003913. Epub 2024 May 6.

引用本文的文献

1
[Dupuytren's disease : Epidemiology, diagnosis, treatment, outcome].
Orthopadie (Heidelb). 2024 Nov;53(11):893-902. doi: 10.1007/s00132-024-04553-z. Epub 2024 Sep 25.
2
Dupuytren's Disease: A Novel Minimally Invasive Pull-Through Technique.
Arch Plast Surg. 2024 Mar 4;51(3):295-303. doi: 10.1055/s-0043-1775882. eCollection 2024 May.

本文引用的文献

1
Outcomes of Management of Recurrent Dupuytren Contracture: A Systematic Review and Meta-analysis.
Hand (N Y). 2022 Nov;17(6):1104-1113. doi: 10.1177/1558944721994220. Epub 2021 Feb 22.
2
Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction.
Plast Reconstr Surg. 2020 Nov;146(5):1071-1079. doi: 10.1097/PRS.0000000000007243.
3
Is Dupuytren's disease really a 'disease of the Vikings'?
J Hand Surg Eur Vol. 2020 Mar;45(3):273-279. doi: 10.1177/1753193419882851. Epub 2019 Oct 30.
4
Outcome of Recurrent Surgery in Dupuytren's Disease: Comparison with Initial Treatment.
Plast Reconstr Surg. 2019 Nov;144(5):828e-835e. doi: 10.1097/PRS.0000000000006150.
5
Outcomes at 7 and 21 years after surgical treatment of Dupuytren's disease by fasciectomy and open-palm technique.
Hand Surg Rehabil. 2018 Oct;37(5):305-310. doi: 10.1016/j.hansur.2018.05.007. Epub 2018 Aug 2.
6
Five-year results after collagenase treatment of Dupuytren disease.
J Hand Surg Eur Vol. 2018 Oct;43(8):841-847. doi: 10.1177/1753193418790157. Epub 2018 Aug 2.
8
Arthrodesis of the proximal interphalangeal joint of the 4th and 5th finger using an interlocking screw device to treat severe recurrence of Dupuytren's disease.
Rev Esp Cir Ortop Traumatol (Engl Ed). 2018 May-Jun;62(3):216-221. doi: 10.1016/j.recot.2017.10.012. Epub 2017 Dec 6.
9
Early Postoperative Results of Percutaneous Needle Fasciotomy in 451 Patients with Dupuytren Disease.
Plast Reconstr Surg. 2017 Jun;139(6):1415-1421. doi: 10.1097/PRS.0000000000003357.
10
Recurrence of Dupuytren's contracture: A consensus-based definition.
PLoS One. 2017 May 15;12(5):e0164849. doi: 10.1371/journal.pone.0164849. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验